A Brookfield/MidOcean consortium has made an NBIO for Origin at A$9/share, a 54.9% premium to last. There is a high probability of this going through. Buy Origin.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.